Axa’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $344K | Buy |
675
+322
| +91% | +$219K | 0.37% | 40 |
|
|
2026
Q1 | $273K | Buy |
+353
| New | +$270K | 0.11% | 66 |
|
|
2025
Q3 | – | Sell |
-62,430
| Closed | -$32.8M | – | 828 |
|
|
2025
Q2 | $32.8M | Sell |
62,430
-20,836
| -25% | -$11.6M | 0.09% | 191 |
|
|
2025
Q1 | $52.8M | Buy |
83,266
+2,902
| +4% | +$2M | 0.17% | 117 |
|
|
2024
Q4 | $57.2M | Sell |
80,364
-6,413
| -7% | -$5.38M | 0.17% | 115 |
|
|
2024
Q3 | $91.2M | Sell |
86,777
-5,877
| -6% | -$6.54M | 0.27% | 82 |
|
|
2024
Q2 | $97.4M | Sell |
92,654
-8,499
| -8% | -$8.24M | 0.29% | 66 |
|
|
2024
Q1 | $97.4M | Sell |
101,153
-9,324
| -8% | -$8.87M | 0.29% | 73 |
|
|
2023
Q4 | $97M | Sell |
110,477
-3,564
| -3% | -$2.93M | 0.31% | 72 |
|
|
2023
Q3 | $93.9M | Buy |
114,041
+685
| +0.6% | +$538K | 0.33% | 71 |
|
|
2023
Q2 | $81.5M | Sell |
113,356
-28,381
| -20% | -$21.9M | 0.27% | 95 |
|
|
2023
Q1 | $116M | Sell |
141,737
-26,010
| -16% | -$19.6M | 0.4% | 54 |
|
|
2022
Q4 | $121M | Buy |
167,747
+41,500
| +33% | +$30.6M | 0.44% | 46 |
|
|
2022
Q3 | $87M | Sell |
126,247
-4,818
| -4% | -$3.03M | 0.34% | 67 |
|
|
2022
Q2 | $77.5M | Sell |
131,065
-3,576
| -3% | -$2.32M | 0.29% | 84 |
|
|
2022
Q1 | $94M | Sell |
134,641
-36,434
| -21% | -$23.1M | 0.27% | 90 |
|
|
2021
Q4 | $108M | Sell |
171,075
-26,003
| -13% | -$16M | 0.28% | 88 |
|
|
2021
Q3 | $119M | Buy |
197,078
+74,696
| +61% | +$46.4M | 0.33% | 68 |
|
|
2021
Q2 | $68.4M | Sell |
122,382
-15,653
| -11% | -$7.93M | 0.19% | 123 |
|
|
2021
Q1 | $65.3M | Buy |
138,035
+14,590
| +12% | +$7.1M | 0.2% | 122 |
|
|
2020
Q4 | $59.6M | Sell |
123,445
-1,993
| -2% | -$1.08M | 0.19% | 130 |
|
|
2020
Q3 | $70.2M | Buy |
125,438
+7,896
| +7% | +$4.79M | 0.25% | 90 |
|
|
2020
Q2 | $73.3M | Buy |
117,542
+34,201
| +41% | +$19.4M | 0.29% | 86 |
|
|
2020
Q1 | $40.7M | Sell |
83,341
-10,438
| -11% | -$4.31M | 0.2% | 119 |
|
|
2019
Q4 | $35.2M | Buy |
93,779
+45,751
| +95% | +$15.4M | 0.14% | 180 |
|
|
2019
Q3 | $13.3M | Sell |
48,028
-1,850
| -4% | -$547K | 0.05% | 391 |
|
|
2019
Q2 | $15.6M | Sell |
49,878
-22,279
| -31% | -$7.42M | 0.06% | 355 |
|
|
2019
Q1 | $29.6M | Buy |
72,157
+1,375
| +2% | +$566K | 0.12% | 226 |
|
|
2018
Q4 | $26.4M | Sell |
70,782
-22,201
| -24% | -$8.13M | 0.12% | 220 |
|
|
2018
Q3 | $37.6M | Hold |
92,983
| – | – | 0.14% | 196 |
|
|
2018
Q2 | $32.1M | Buy |
92,983
+1,101
| +1% | +$344K | 0.12% | 214 |
|
|
2018
Q1 | $31.6M | Sell |
91,882
-1,296
| -1% | -$451K | 0.13% | 198 |
|
|
2017
Q4 | $35M | Sell |
93,178
-283
| -0.3% | -$115K | 0.14% | 204 |
|
|
2017
Q3 | $41.8M | Sell |
93,461
-18,450
| -16% | -$8.78M | 0.18% | 168 |
|
|
2017
Q2 | $55M | Buy |
111,911
+30,769
| +38% | +$13.5M | 0.25% | 113 |
|
|
2017
Q1 | $31.4M | Sell |
81,142
-5,057
| -6% | -$1.87M | 0.14% | 200 |
|
|
2016
Q4 | $31.6M | Sell |
86,199
-16,265
| -16% | -$6.19M | 0.15% | 185 |
|
|
2016
Q3 | $41.2M | Buy |
102,464
+50
| +0% | +$20.1K | 0.18% | 159 |
|
|
2016
Q2 | $35.8M | Sell |
102,414
-3,609
| -3% | -$1.39M | 0.16% | 176 |
|
|
2016
Q1 | $38.2M | Buy |
106,023
+677
| +0.6% | +$279K | 0.17% | 164 |
|
|
2015
Q4 | $57.2M | Sell |
105,346
-1,303
| -1% | -$706K | 0.25% | 112 |
|
|
2015
Q3 | $49.6M | Sell |
106,649
-1,955
| -2% | -$1.05M | 0.2% | 136 |
|
|
2015
Q2 | $55.4M | Sell |
108,604
-900
| -0.8% | -$439K | 0.22% | 129 |
|
|
2015
Q1 | $49.4M | Sell |
109,504
-4,333
| -4% | -$1.84M | 0.2% | 143 |
|
|
2014
Q4 | $46.7M | Sell |
113,837
-7,079
| -6% | -$2.78M | 0.19% | 151 |
|
|
2014
Q3 | $43.6M | Buy |
120,916
+75,523
| +166% | +$25.3M | 0.19% | 156 |
|
|
2014
Q2 | $12.8M | Sell |
45,393
-1,806
| -4% | -$535K | 0.05% | 353 |
|
|
2014
Q1 | $14.2M | Sell |
47,199
-14,510
| -24% | -$4.47M | 0.06% | 311 |
|
|
2013
Q4 | $17M | Sell |
61,709
-26,137
| -30% | -$7.52M | 0.08% | 275 |
|
|
2013
Q3 | $27.5M | Sell |
87,846
-6,647
| -7% | -$1.75M | 0.14% | 182 |
|
|
2013
Q2 | $21.3M | Buy |
+94,493
| New | +$22M | 0.11% | 203 |
|
Other funds holding REGN
Axa's REGN Position: Q2 2026 in Review
Axa increased its Regeneron Pharmaceuticals (REGN) stake by 91% in Q2 2026, buying an estimated $219K and bringing the position to 675 shares worth $344K. The position accounts for 0.37% of the portfolio, ranked #40.
Axa first reported a position in REGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $121M in Q4 2022. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Axa held 675 shares of Regeneron Pharmaceuticals worth $344K as of Q2 2026.
- Axa bought 322 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $219K.
- Regeneron Pharmaceuticals made up 0.37% of Axa's portfolio in Q2 2026, its #40 holding.
- Axa first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- Axa's Regeneron Pharmaceuticals position peaked at $121M in Q4 2022.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Axa's 13F filing for Q2 2026, filed 14 Aug 2026.